CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ:CRIS), a drug development company focused on seeking to develop proprietary targeted medicines primarily for cancer treatment, today announced that the Company will be presenting at the Wall Street Analyst Forum’s 18th Annual Conference on September 20, 2007, at the Princeton Club in New York City.
